The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
A randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer (KOV-HIPEC-02). This is an ASCO Meeting Abstract from ...
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
AI would identify new drug targets, generate molecules, and compress years of chemistry into weeks. Those promises were not ...
Elemento is the director of the Englander Institute for Precision Medicine at Weill Cornell Medicine. Sternberg is the clinical director of the Englander Institute for Precision Medicine. Khozin is ...
Early cancer screening can play a transformative role in healthcare, potentially saving lives by identifying cancer before it progresses to an advanced, less treatable stage. However, designing ...
YouTube on MSN
Lowering Cholesterol Killed: A Study Buried for 40 Years
A forgotten trial, buried for decades, revealed that a cholesterol-lowering didn’t save lives—it cost them. Here’s what the ...
Protocol fidelity and transparency about changes are essential to the credibility of randomised controlled trials In recent ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results